Insider · CIK 0001765473

Oxtoby Andrew

Reports to the SEC for 3 companies · BERKELEY HEIGHTS, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001765473

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-19	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+222K sh	—	—	222,000
2025-04-10	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+287K sh	—	—	287,000
2025-03-18	KLRSKalaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+477K sh	—	—	476,611
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−160K sh	$18.18	−$2.91M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−40K sh	—	—	0
2023-02-28	CHINOOK THERAPEUTICS, INC.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+160K sh	—	—	160,000
2023-02-28	CHINOOK THERAPEUTICS, INC.Restricted Stock (RSU)(Common Stock)A Award	Chief Commercial Officer	AAward	+40K sh	—	—	40,000
2020-10-13	Aimmune Therapeutics, Inc.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−20.3K sh	$34.50	−$699K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−150K sh	$12.56	−$1.88M	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−67.5K sh	$10.69	−$722K	0
2020-10-10	Aimmune Therapeutics, Inc.U Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	−6,345 sh	$34.50	−$219K	0
2020-09-15	Aimmune Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−840 sh	$34.25	−$28.8K	26,595
2020-05-10	Aimmune Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+2,420 sh	—	—	27,435
2020-03-13	Aimmune Therapeutics, Inc.P Purchase	Chief Commercial Officer	PPurchase	+3,000 sh	$14.76	+$44.3K	25,015
2020-02-28	Aimmune Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+11.3K sh	—	—	23,250
2020-02-28	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+67.5K sh	—	—	67,500
2020-02-28	Aimmune Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+11.3K sh	—	—	22,015
2020-02-28	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+67.5K sh	—	—	67,500
2020-01-22	Aimmune Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,235 sh	$33.23	−$41K	10,765
2019-01-22	Aimmune Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+12K sh	—	—	12,000
2019-01-22	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Mar 204
Oxtoby Andrew0001193125-26-117618
SEC(opens sec.gov)
Apr 114
Oxtoby Andrew0000950170-25-053347
SEC(opens sec.gov)
Mar 184
Oxtoby Andrew0000950170-25-041485
SEC(opens sec.gov)
Aug 114
Oxtoby Andrew0001209191-23-045429
SEC(opens sec.gov)
Mar 24
Oxtoby Andrew0001209191-23-014787
SEC(opens sec.gov)
Oct 144
Oxtoby Andrew0000899243-20-028183
SEC(opens sec.gov)
Sep 164
Oxtoby Andrew0000899243-20-025349
SEC(opens sec.gov)
May 124
Oxtoby Andrew0000899243-20-012853
SEC(opens sec.gov)
Mar 174
Oxtoby Andrew0000899243-20-008621
SEC(opens sec.gov)
Mar 44/A
Oxtoby Andrew0000899243-20-007111
SEC(opens sec.gov)
Mar 44
Oxtoby Andrew0000899243-20-007110
SEC(opens sec.gov)
Mar 34
Oxtoby Andrew0000899243-20-006850
SEC(opens sec.gov)
Jan 244
Oxtoby Andrew0000899243-19-001869
SEC(opens sec.gov)

Companies

Address

C/O KALARIS THERAPEUTICS, INC. 400 CONNELL DRIVE, SUITE 5500

BERKELEY HEIGHTS, NJ, 07922